Koshizuka Keiichi, Hanazawa Toyoyuki, Arai Takayuki, Okato Atsushi, Kikkawa Naoko, Seki Naohiko
Department of Functional Genomics, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.
Department of Otorhinolaryngology/Head and Neck Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Cancer Metastasis Rev. 2017 Sep;36(3):525-545. doi: 10.1007/s10555-017-9692-y.
MicroRNAs (miRNAs) are small noncoding RNAs that act as fine-tuners of the post-transcriptional control of protein-coding or noncoding RNAs by repressing translation or cleaving RNA transcripts in a sequence-dependent manner in cells. Accumulating evidence have been indicated that aberrantly expressed miRNAs are deeply involved in human pathogenesis, including cancers. Surprisingly, these small, single-stranded RNAs (18-23 nucleotides) have been shown to function as antitumor or oncogenic RNAs in several types of cancer cells. A single miRNA has regulating hundreds or thousands of different mRNAs, and individual mRNA has been regulated by multiple different miRNAs in normal cells. Therefore, tightly controlled RNA networks can be disrupted by dysregulated of miRNAs in cancer cells. Investigation of novel miRNA-mediated RNA networks in cancer cells could provide new insights in the field of cancer research. In this review, we focus on head and neck squamous cell carcinoma (HNSCC) and discuss current findings of the involvement of aberrantly expressed miRNAs in the pathogenesis of HNSCC.
微小RNA(miRNA)是一类小的非编码RNA,它们通过在细胞中以序列依赖的方式抑制翻译或切割RNA转录本,充当蛋白质编码或非编码RNA转录后调控的微调器。越来越多的证据表明,异常表达的miRNA与包括癌症在内的人类发病机制密切相关。令人惊讶的是,这些小的单链RNA(18 - 23个核苷酸)在几种类型的癌细胞中已被证明可作为抗肿瘤或致癌RNA发挥作用。单个miRNA可调控数百或数千种不同的mRNA,而在正常细胞中,单个mRNA受到多种不同miRNA的调控。因此,癌细胞中miRNA的失调会破坏紧密控制的RNA网络。对癌细胞中新型miRNA介导的RNA网络的研究可为癌症研究领域提供新的见解。在本综述中,我们聚焦于头颈部鳞状细胞癌(HNSCC),并讨论异常表达的miRNA参与HNSCC发病机制的当前研究结果。